Present status and future prospects for the hybridoma technology.
A somatic cell genetic technique has recently been developed that makes it possible to obtain very large amounts of homogeneous antibodies and to replenish the supply of the exact same antibodies whenever they are needed. This hybridoma technology has already contributed to major scientific advances and will surely improve the diagnosis and treatment of many diseases. Because the technology itself is relatively simple and inexpensive, it has captured the attention of basic scientists, clinicians, and industrial managers and investors.
D000818:Animals; D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D000918:Antibody Specificity; D000951:Antigens, Neoplasm; D000954:Antigens, Surface; D000956:Antigens, Viral; D002459:Cell Fusion; D002999:Clone Cells; D006801:Humans; D006825:Hybridomas; D008722:Methods; D051379:Mice; D009154:Mutation; D013045:Species Specificity; D013601:T-Lymphocytes / Q000276:immunology; D014780:Viruses / Q000276:immunology
D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D000954:Antigens, Surface; D000956:Antigens, Viral